MARIA STRANGIE: Open Payments
NPI 1073159992 · RUTHERFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,470 in 154 payments from 19 companies in 2025. Trend: 2023 $801 · 2024 $1,791 · 2025 $2,470
Food & beverage: $2,118Education: $352
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $502 |
| Lilly USA, LLC | 16 | $269 |
| UCB, Inc. | 29 | $260 |
| ABBVIE INC. | 20 | $251 |
| GENZYME CORPORATION | 12 | $203 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $187 |
| Arcutis Biotherapeutics, Inc. | 14 | $162 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 7 | $121 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $69 |
Products named: TREMFYA, DUPIXENT, Bimzelx, EBGLYSS, Zoryve, SKYRIZI, SILIQ, RINVOQ.
Industry payments across NJ — which companies pay providers there.
